NDC directory

Tocilizumab-anoh

tocilizumab-anoh · CELLTRION USA, Inc. · INJECTION, SOLUTION

72606-051BLAInterleukin 6 Receptor Antagonists [MoA]
Product NDC
72606-051
Generic name
tocilizumab-anoh
Labeler name
CELLTRION USA, Inc.
Brand name
Tocilizumab-anoh
Finished
true
Listing expiration date
20271231
Marketing category
BLA
Dosage form
INJECTION, SOLUTION
SPL ID
b01afa28-11e4-47f0-9b78-bdcd8ee9e99a
Product type
HUMAN PRESCRIPTION DRUG
Marketing start date
20261001
Product ID
72606-051_b01afa28-11e4-47f0-9b78-bdcd8ee9e99a
Application number
BLA761498
Brand name base
Tocilizumab-anoh
Active ingredients
  1. Name
    TOCILIZUMAB
    Strength
    162 mg/.9mL
Packaging
  1. Package NDC
    72606-051-01
    Description
    1 SYRINGE, GLASS in 1 CARTON (72606-051-01) / .9 mL in 1 SYRINGE, GLASS
    Marketing start date
    20261001
    Sample
    false
  2. Package NDC
    72606-051-04
    Description
    1 SYRINGE, GLASS in 1 CARTON (72606-051-04) / .9 mL in 1 SYRINGE, GLASS
    Marketing start date
    20261001
    Sample
    false
Route
SUBCUTANEOUS
Pharm class
Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.